OrthoPediatrics’ (KIDS) Buy Rating Reiterated at Needham & Company LLC

OrthoPediatrics (NASDAQ:KIDS)‘s stock had its “buy” rating reiterated by investment analysts at Needham & Company LLC in a report issued on Tuesday,Benzinga reports. They presently have a $42.00 price target on the stock. Needham & Company LLC’s price target would indicate a potential upside of 68.00% from the stock’s current price.

Separately, Truist Financial dropped their price objective on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a report on Wednesday, December 18th.

OrthoPediatrics Price Performance

Shares of NASDAQ:KIDS opened at $25.00 on Tuesday. The company has a market cap of $605.40 million, a price-to-earnings ratio of -20.33 and a beta of 1.14. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68. The firm has a 50 day simple moving average of $24.20 and a 200 day simple moving average of $27.41. OrthoPediatrics has a one year low of $21.02 and a one year high of $35.99.

Institutional Investors Weigh In On OrthoPediatrics

Hedge funds have recently added to or reduced their stakes in the business. Wellington Management Group LLP increased its stake in shares of OrthoPediatrics by 16.2% in the 3rd quarter. Wellington Management Group LLP now owns 883,221 shares of the company’s stock valued at $23,944,000 after acquiring an additional 122,846 shares in the last quarter. State Street Corp increased its holdings in shares of OrthoPediatrics by 1.0% during the third quarter. State Street Corp now owns 417,898 shares of the company’s stock valued at $11,329,000 after acquiring an additional 4,236 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of OrthoPediatrics by 2.1% during the third quarter. Geode Capital Management LLC now owns 391,492 shares of the company’s stock valued at $10,615,000 after acquiring an additional 7,972 shares in the last quarter. Portolan Capital Management LLC increased its stake in OrthoPediatrics by 66.2% during the 3rd quarter. Portolan Capital Management LLC now owns 308,099 shares of the company’s stock valued at $8,353,000 after purchasing an additional 122,770 shares in the last quarter. Finally, Harbor Capital Advisors Inc. increased its stake in OrthoPediatrics by 1.9% during the 4th quarter. Harbor Capital Advisors Inc. now owns 251,588 shares of the company’s stock valued at $5,832,000 after purchasing an additional 4,728 shares in the last quarter. 69.05% of the stock is currently owned by institutional investors.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.